1. Schottenfeld D Fraumeni JF Cancer epidemiology and prevention. 3rd edn. Oxford University Press , Oxford View in Article Crossref

Google Scholar

2. International Agency for Research on Cancer GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Default.aspx View in Article Google Scholar

3. WHO Cancer prevention and control in the context of an integrated approach: report by the Secretariat. World Health Organization , Geneva View in Article Google Scholar

4. WHO Cancer prevention and control [WHA 58.22]. World Health Organization , Geneva View in Article Google Scholar

8. Centers for Disease Control and Prevention Cancer survival: the start of global surveillance. https://www.cdc.gov/cancer/dcpc/research/articles/CONCORD-2.htm Date: 2015 View in Article Google Scholar

10. Independent Cancer Taskforce Achieving world-class cancer outcomes: a strategy for England 2015–2020. NHS England , London View in Article Google Scholar

11. International Atomic Energy Agency Access to cancer therapy. https://www.youtube.com/watch?v=cXJ79_hxdNA Date: Nov 20, 2015 View in Article Google Scholar

12. International Atomic Energy Agency PACT's new campaign raises awareness of the persistent inequalities in access to lifesaving cancer services: PACT highlights the growing global divide in cancer survival rates. https://cancer.iaea.org/newsstory.asp?id=167 Date: Sept 11, 2015 View in Article Google Scholar

14. Allemani C

Coleman MP Public health surveillance of cancer survival in the US and world-wide: the contribution of the CONCORD programme. Cancer. 123 : 4977-4981 View in Article Scopus (10)

PubMed

Crossref

Google Scholar

15. Ferlay J

Soerjomataram I

Dikshit R

et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136 : E359-E386 View in Article Scopus (15995)

PubMed

Crossref

Google Scholar

16. UN Statistical Division Standard country or area codes for statistical use (M49). https://unstats.un.org/unsd/methodology/m49/ Date: 2015 View in Article Google Scholar

17. Fritz AG Percy C Jack A International classification of diseases for oncology (ICD-O). 3rd edn. World Health Organization , Geneva View in Article Google Scholar

18. Fritz AG Percy C Jack A International Classification of diseases for oncology (ICD-O). first revision of 3rd edn. World Health Organization , Geneva View in Article Google Scholar

19. Sant M

Karjalainen-Lindsberg ML

Maynadié M

et al. Manual for coding and reporting haematological malignancies. Tumori. 96 : i-A32 View in Article PubMed

Google Scholar

22. Morton LM

Turner JJ

Cerhan JR

et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 110 : 695-708 View in Article Scopus (300)

PubMed

Crossref

Google Scholar

23. Turner JJ

Morton LM

Linet MS

et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 116 : e90-e98 View in Article Scopus (161)

PubMed

Crossref

Google Scholar

24. Woods LM

Rachet B

Ellis L

Coleman MP Full dates (day, month, year) should be used in population-based cancer survival studies. Int J Cancer. 131 : E1120-E1124 View in Article Scopus (6)

PubMed

Crossref

Google Scholar

25. Surveillance Epidemiology and End Results program Multiple primary and histology coding rules manual. National Cancer Institute , Bethesda, MD View in Article Google Scholar

28. United Nations World population prospects: the 2015 revision. Department of Economic and Social Affairs, Population Division , http://esa.un.org/unpd/wpp/ View in Article Crossref

Google Scholar

30. Estève J

Benhamou E

Raymond L Statistical methods in cancer research, volume IV. Descriptive epidemiology (IARC Scientific Publications no. 128). International Agency for Research on Cancer , Lyon View in Article Google Scholar

33. Brenner H

Spix C Combining cohort and period methods for retrospective time trend analyses of long-term cancer patient survival rates. Br J Cancer. 89 : 1260-1265 View in Article Scopus (12)

PubMed

Crossref

Google Scholar

35. Clerc-Urmès I

Grzebyk M

Hédelin G Net survival estimation with stns. Stata J. 14 : 87-102 View in Article Google Scholar

36. Rachet B

Maringe C

Woods LM

Ellis L

Spika D

Allemani C Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations. BMC Public Health. 15 : 1240 View in Article Scopus (19)

PubMed

Crossref

Google Scholar

37. Micheli A

Baili P

Mugno E

et al. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol. 14 : 28-40 View in Article Scopus (52)

PubMed

Crossref

Google Scholar

39. Brass W On the scale of mortality. in: Brass W Biological aspects of demography. Taylor and Francis , London : 69-110 View in Article Google Scholar

40. Elandt-Johnson RC

Johnson NL Survival models and data analysis (Wiley series in probability and mathematical statistics). John Wiley & Sons , Indianapolis, IN View in Article Google Scholar

43. Greenwood M The natural duration of cancer. Report on public health and medical subjects no. 33. HM Stationery Office , London View in Article Google Scholar

44. Berkson J

Gage RP Survival curve for cancer patients following treatment. J Am Stat Assoc. 47 : 501-515 View in Article Scopus (484)

Crossref

Google Scholar

47. Allemani C. The importance of global surveillance of cancer survival for cancer control: the CONCORD programme. Cancer Control (in press). View in Article Google Scholar

48. Abdel-Rahman MA

Stockton DL

Rachet B

Hakulinen T

Coleman MP What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?. Br J Cancer. 101 : 115-124 View in Article Scopus (126)

PubMed

Crossref

Google Scholar

50. Ho GF

Taib NA

Pritam Singh RK

Yip CH

Abdullah MM

Lim TO What if all patients with breast cancer in Malaysia have access to the best available care: how many deaths are avoidable?. Glob J Health Sci. 9 : 32-39 View in Article Crossref

Google Scholar

51. Pokhrel A

Martikainen P

Pukkala E

Rautalahti M

Seppä K

Hakulinen T Education, survival and avoidable deaths in cancer patients in Finland. Br J Cancer. 103 : 1009-1114 View in Article Scopus (43)

Crossref

Google Scholar

52. Sandiford P

Abdel-Rahman ME

Allemani C

Coleman MP

Gala G How many cancer deaths could New Zealand avoid if five-year relative survival ratios were the same as in Australia?. Aust NZ J Public Health. 39 : 157-161 View in Article Scopus (6)

PubMed

Crossref

Google Scholar

54. Mirzaei M

Mirzadeh M

Mirzaei M Expected years of life lost due to adult cancer mortality in Yazd (2004–2010). Asian Pac J Cancer Prev. 17 : 101-105 View in Article Scopus (6)

PubMed

Crossref

Google Scholar

55. Brustugun OT

Møller B

Helland Å Years of life lost as a measure of cancer burden on a national level. Br J Cancer. 111 : 1014-1020 View in Article Scopus (46)

PubMed

Crossref

Google Scholar

57. Woods LM

Morris M

Rachet B No ‘cure’ within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989–2011. Ann Oncol. 27 : 2025-2031 View in Article Scopus (5)

PubMed

Crossref

Google Scholar

58. Andersson TML

Eriksson H

Hansson J

et al. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study. Cancer Epidemiol. 38 : 93-99 View in Article Scopus (14)

PubMed

Crossref

Google Scholar

59. Gatta G

Rossi S

Foschi R

et al. Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002. Haematologica. 98 : 744-752 View in Article Scopus (27)

PubMed

Crossref

Google Scholar

60. Ito Y

Nakayama T

Tsukuma H

et al. Role of age and tumour stage in the temporal pattern of ‘cure’ from stomach cancer: a population-based study in Osaka, Japan. Cancer Epidemiol. 36 : 128-132 View in Article Scopus (7)

PubMed

Crossref

Google Scholar

61. Shack LG

Shah A

Lambert P

Rachet B “Cure” by age and stage at diagnosis for colorectal cancer patients: a population-based study. Cancer Epidemiol. 36 : 548-553 View in Article Scopus (14)

PubMed

Crossref

Google Scholar

62. Coleman MP Why we need global surveillance of cancer survival: the CONCORD programme. in: McGrath I Cancer care in emerging health systems. International Network for Cancer Treatment and Research , Oxford : 60-65 View in Article Google Scholar

64. OECD Cancer care: assuring quality to improve survival. Organisation for Economic Co-operation and Development , Paris View in Article Crossref

Google Scholar

67. OECD Health at a glance 2017: OECD indicators. Organisation for Economic Co-operation and Development , Paris View in Article Crossref

Google Scholar

68. UICC World Cancer Declaration 2013. Union for International Cancer Control , Geneva View in Article Google Scholar

69. Jensen OM Parkin DM MacLennan R Muir CS Skeet RG Cancer registration: principles and methods (IARC Scientific Publications no. 95). International Agency for Research on Cancer , Lyon View in Article Google Scholar

70. Berrino F

Estève J

Coleman MP Basic issues in the estimation and comparison of cancer patient survival. in: Berrino F Sant M Verdecchia A Capocaccia R Hakulinen T Estève J Survival of cancer patients in Europe: the EUROCARE study (IARC Scientific Publications no. 132). International Agency for Research on Cancer (WHO) , Lyon : 1-14 View in Article Google Scholar

72. Laurenti R

Coleman MP

Aylin P Accuracy of statements of the cause of death on death certificates and the international comparability of mortality statistics. in: Coleman MP Aylin P Death certification and mortality statistics: an international perspective. Office for National Statistics , London : 1-9 View in Article Google Scholar

73. Ovcharov VK

Tishuk EA The improvement of statistical records of the causes of death in Russia. in: Coleman MP Aylin P Death certification and mortality statistics: an international perspective. Office for National Statistics , London : 28-30 View in Article Google Scholar

74. Filippatos G

Andriopoulos P

Panoutsopoulos G

et al. The quality of death certification practice in Greece. Hippokratia. 20 : 19-25 View in Article PubMed

Google Scholar

75. Haghighi MH

Dehghani M

Teshizi SH

Mahmoodi H Impact of documentation errors on accuracy of cause of death coding in an educational hospital in Southern Iran. HIM J. 43 : 35-42 View in Article Crossref

Google Scholar

76. Cândida da Cunha C

Teixeira R

França E Assessment of the investigation of ill-defined causes of death in Brazil in 2010. Epidemiol Serv Saude. 26 : 1-12 View in Article Google Scholar

77. Antoni S

Soerjomataram I

Møller B

Bray F

Ferlay J An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence. Bull World Health Organ. 94 : 174-184 View in Article Scopus (50)

PubMed

Crossref

Google Scholar

78. Engeland A

Haldorsen T

Dickman PW

et al. Relative survival of cancer patients: a comparison between Denmark and other Nordic countries. Acta Oncol. 37 : 49-59 View in Article Scopus (70)

PubMed

Crossref

Google Scholar

79. Berrino F Capocaccia R Estève J Survival of cancer patients in Europe: the EUROCARE-2 study (IARC Scientific Publications no. 151). International Agency for Research on Cancer , Lyon View in Article Google Scholar

80. Storm HH

Gislum M

Engholm G Cancer survival before and after initiating the Danish Cancer Control plan. Ugeskr Læger. 170 : 3065-3069 View in Article PubMed

Google Scholar

81. Engholm G

Ferlay J

Christensen N

et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, version 7.3 (08.07.2016). Association of the Nordic Cancer Registries, Danish Cancer Society , http://www.ancr.nu View in Article Google Scholar

82. Storm HH

Engholm G

Hakulinen T

et al. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results. Acta Oncol. 49 : 532-544 View in Article Scopus (48)

PubMed

Crossref

Google Scholar

84. Choi KS

Jun JK

Suh M

et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br J Cancer. 112 : 608-612 View in Article Scopus (62)

PubMed

Crossref

Google Scholar

87. Chang JW-C

Guo J

Hung C-Y

et al. Sunrise in melanoma management: time to focus on melanoma burden in Asia. Asia Pac J Clin Oncol. 13 : 423-427 View in Article Scopus (7)

PubMed

Crossref

Google Scholar

89. Marcus PM

Prorok PC

Miller AB

DeVoto EJ

Kramer BS Conceptualizing overdiagnosis in cancer screening. J Natl Cancer Inst. 107 : 1-4 View in Article Scopus (52)

Crossref

Google Scholar

90. Allemani C

Rachet B

Weir HK

et al. Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open. 3 : e003055 View in Article Scopus (38)

PubMed

Crossref

Google Scholar

91. Maringe C

Walters S

Rachet B

et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol. 52 : 919-932 View in Article Scopus (123)

PubMed

Crossref

Google Scholar

92. Wu SJ

Chiang CJ

Lin CT

Tien HF

Lai MS Improving but inferior survival in patients with chronic lymphocytic leukemia in Taiwan: a population-based study, 1990–2004. PLoS One. 8 : e62930 View in Article Scopus (13)

PubMed

Crossref

Google Scholar

99. Beaulieu N

Bloom D

Bloom R

Stein R Breakaway: the global burden of cancer—challenges and opportunities. A report from the Economist Intelligence Unit. The Economist , London View in Article Google Scholar

100. Mariotto AB

Yabroff KR

Shao Y

Feuer EJ

Brown ML Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 103 : 117-128 View in Article Scopus (1437)

PubMed

Crossref

Google Scholar

102. Knaul FM

Gralow J

Atun R

Bhadelia A Closing the cancer divide: an equity imperative. Harvard University Press , Boston, MA View in Article Google Scholar

104. Tangka FKL

Subramanian S

Beebe MC

et al. Cost of operating central cancer registries and factors that affect cost: findings from an economic evaluation of Centers for Disease Control and Prevention National Program of Cancer Registries. J Public Health Manag Pract. 22 : 452-460 View in Article Scopus (13)

PubMed

Crossref

Google Scholar